Inovalon Holdings (INOV) Earning Somewhat Favorable News Coverage, Accern Reports

News articles about Inovalon Holdings (NASDAQ:INOV) have trended somewhat positive this week, Accern reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Inovalon Holdings earned a news impact score of 0.15 on Accern’s scale. Accern also gave news articles about the technology company an impact score of 45.2144079688636 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Here are some of the media headlines that may have effected Accern Sentiment Analysis’s analysis:

A number of research firms recently commented on INOV. TheStreet upgraded Inovalon Holdings from a “d+” rating to a “c-” rating in a report on Thursday, October 5th. BidaskClub downgraded Inovalon Holdings from a “buy” rating to a “hold” rating in a report on Friday, August 11th. KeyCorp restated a “hold” rating on shares of Inovalon Holdings in a report on Tuesday, September 12th. ValuEngine upgraded Inovalon Holdings from a “sell” rating to a “hold” rating in a report on Wednesday, September 6th. Finally, Morgan Stanley upgraded Inovalon Holdings from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $9.00 to $14.00 in a report on Tuesday, September 12th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. The company has an average rating of “Hold” and an average target price of $14.00.

Inovalon Holdings (NASDAQ:INOV) opened at 16.80 on Wednesday. Inovalon Holdings has a 12-month low of $8.60 and a 12-month high of $17.80. The firm has a market cap of $2.45 billion, a P/E ratio of 141.18 and a beta of 1.31. The company has a 50-day moving average price of $16.68 and a 200-day moving average price of $16.68.

Inovalon Holdings (NASDAQ:INOV) last released its earnings results on Wednesday, August 2nd. The technology company reported $0.08 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.07 by $0.01. The firm had revenue of $110.60 million for the quarter, compared to analysts’ expectations of $108.73 million. Inovalon Holdings had a return on equity of 5.17% and a net margin of 4.13%. The business’s quarterly revenue was down 10.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.14 EPS. On average, analysts predict that Inovalon Holdings will post $0.32 earnings per share for the current year.

In other news, CEO Keith R. Dunleavy bought 62,000 shares of the business’s stock in a transaction on Wednesday, September 13th. The shares were purchased at an average price of $16.38 per share, for a total transaction of $1,015,560.00. Following the purchase, the chief executive officer now owns 270,000 shares of the company’s stock, valued at approximately $4,422,600. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 48.28% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at

About Inovalon Holdings

Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.

Insider Buying and Selling by Quarter for Inovalon Holdings (NASDAQ:INOV)

Receive News & Ratings for Inovalon Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply